-Hindustan Times Prominent Indian banks have claimed there is no cash crunch, but fact remains that ATMs run dry during long weekends. The crisis began in November when the Union government pulled 500 and 1000 rupee banknotes from circulation as a part of its crackdown on black money. New Delhi: It has been six months since demonetisation, but, “Is there cash in the ATM?” continues to be the most popular question...

-The Hindu Business Line Sees enhanced infra spending, higher consumption New Delhi: While noting that demonetisation of high value currency by the government last year will help bring in more taxpayers into the tax net, the United Nations ESCAP in a new report has said that more measures will be required to fight black money in the future. “The measure did not, by itself, impede future black money flows in new denominations. …...

-The Telegraph New Delhi: Bihar chief minister Nitish Kumar today highlighted "contradictions" in the Narendra Modi government's anti-Maoist policy, accusing it of stopping key security and development schemes in the rebel zones. He questioned the utility of convening security review meetings with the chief ministers of the Maoist-hit states - like the one held in Delhi today - when the Centre was not releasing funds to fight the rebels. Union home minister Rajnath...

-The Times of India NEW DELHI: Acknowledging that women are a disadvantaged section despite comprising nearly half of the population of the country, the Centre is considering lowering income tax for single women, introducing Aadhaar-linked health cards for free basic health check-ups for women and cashless medical service for those who are pregnant. A national policy for women, framed by a group of ministers headed by external affairs minister Sushma Swaraj, is...

-The Telegraph New Delhi: The World Health Organisation has announced a plan to approve generic versions of two expensive bio-therapeutic anti-cancer molecules in an effort to make them available to low and middle-income countries. It said it would invite manufacturers to submit applications for pre-qualification of biologically similar versions of rituximab, used to treat chronic lymphocytic leukaemia and non-Hodgkin's lymphoma, and trastuzumab, used to treat breast cancer. The pre-qualification process is a mechanism...